Valuation China Shineway Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 04:08:09 2026-10-23 EDT			5-day change	1st Jan Change
7.275 ^HKD	+0.76%		-2.22%	-15.41%

09-29	China Shineway Pharmaceutical Group Limited Announces Board and Committee Changes, Effective 1 October 2026	CI
09-18	China Shineway Pharmaceutical Group Limited Declares Special Interim Dividend in Respect of the Fiscal Year Ending 31 December 2026, Payable on 15 October 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,240	5,072	4,985	6,850	5,838	4,674	-	-
Change	-	19.61%	-1.71%	37.41%	-14.78%	-19.93%	-	-
Enterprise Value (EV)	49.32	25.13	4,985	6,850	5,838	4,674	4,674	4,674
Change	-	-49.04%	19,734.74%	37.41%	-14.78%	-19.93%	0%	0%
P/E	7.59x	6.99x	5.16x	8.17x	6.13x	6.19x	5.76x	5.41x
PBR	0.72x	0.79x	0.71x	-	0.72x	0.59x	-	-
PEG	-	0.2x	0.2x	-0.6x	0.5x	-0.3x	0.78x	0.84x
Capitalization / Revenue	1.32x	1.28x	1.1x	1.81x	1.86x	1.99x	1.99x	1.93x
EV / Revenue	0x	0x	0x	0x	0x	1.99x	1.99x	1.93x
EV / EBITDA	0x	0x	0x	0x	0x	5.75x	5.4x	5.13x
EV / EBIT	0x	0x	0x	0x	0x	5.75x	5.4x	5.13x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	0.39	0.32	0.42	0.54	-	-	-	-
Rate of return	6.95%	4.77%	6.36%	5.95%	-	-	-	-
EPS ²	0.74	0.96	1.28	1.11	1.26	1	1.074	1.143
Distribution rate	52.7%	33.3%	32.8%	48.6%	-	-	-	-
Net sales ¹	3,224	3,951	4,517	3,778	3,135	2,344	2,347	2,427
EBITDA ¹	826	1,022	1,316	1,306	1,047	813	865	911
EBIT ¹	643.6	835.8	1,139	1,025	896	813	865	911
Net income ¹	556.7	722.8	969.5	840.1	949.9	755	811	864
Net Debt	-4,191	-5,046	-	-	-	-	-	-
Reference price ²	5.613	6.714	6.599	9.068	7.728	6.188	6.188	6.188
Nbr of stocks (in thousands)	755,400	755,400	755,400	755,400	755,400	755,400	-	-
Announcement Date	3/29/22	3/30/23	3/28/24	3/28/25	3/27/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED	6.19x	-	-	-	701M
ELI LILLY AND COMPANY	36.74x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.5x	18.29x	2.02%	636B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.67x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.42x	4.53x	12.96x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	27.13x	7.04x	18.70x	2.12%	400.5B
Weighted average by Cap.	35.13x	8.29x	20.39x	1.8%